Get the Stockscreener App
0.1557
10.41%
-0.0181
Accuray Inc stock is traded at $0.1557, with a volume of 1.94M.
It is down -10.41% in the last 24 hours and down -33.18% over the past month.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
See More
Previous Close:
$0.1738
Open:
$0.1731
24h Volume:
1.94M
Relative Volume:
0.96
Market Cap:
$18.60M
Revenue:
$436.97M
Net Income/Loss:
$-35.62M
P/E Ratio:
-0.522
EPS:
-0.2983
Net Cash Flow:
$-10.71M
1W Performance:
-32.22%
1M Performance:
-33.18%
6M Performance:
-65.03%
1Y Performance:
-91.15%
1-Day Range:
$0.1533
$0.1794
1-Week Range:
$0.1533
$0.2278
52-Week Range:
$0.1533
$1.86
Accuray Inc Stock (ARAY) Company Profile
Name
Accuray Inc
Sector
Industry
Phone
608-824-2800
Address
1240 DEMING WAY, MADISON, CA
Compare ARAY vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
0.1557 | 18.60M | 436.97M | -35.62M | -10.71M | -0.2983 |
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-07-26 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-13-24 | Initiated | ROTH MKM | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Dec-22-21 | Initiated | Loop Capital | Buy |
| Jan-21-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-01-18 | Upgrade | Citigroup | Sell → Neutral |
| Dec-13-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-17 | Initiated | Lake Street | Buy |
| Dec-14-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-22-15 | Initiated | RBC Capital Mkts | Sector Perform |
| Nov-12-15 | Initiated | Citigroup | Sell |
| May-01-15 | Reiterated | Dougherty & Company | Buy |
| Jan-12-15 | Initiated | Northland Capital | Outperform |
| Jan-31-14 | Reiterated | Dougherty & Company | Buy |
| Jan-29-14 | Reiterated | Brean Capital | Buy |
| Nov-11-13 | Reiterated | Dougherty & Company | Buy |
| Aug-29-13 | Reiterated | Dougherty & Company | Buy |
| Sep-20-11 | Reiterated | Ticonderoga | Buy |
| Feb-08-10 | Upgrade | Jefferies & Co | Hold → Buy |
| Dec-09-09 | Upgrade | UBS | Sell → Neutral |
| Mar-09-09 | Downgrade | Soleil | Buy → Hold |
| Jan-30-09 | Upgrade | Piper Jaffray | Neutral → Buy |
| Dec-22-08 | Reiterated | Jefferies & Co | Hold |
| Aug-20-08 | Reiterated | Jefferies & Co | Hold |
View All
Accuray Inc Stock (ARAY) Latest News
Accuray Director Richard Meier Awarded 75,000 RSUs and Stock Options in October 2026 - Kalkine Media
Accuray Announces Stockholder Approval of Key - Moomoo
Accuray Inc (ARAY) Stockholders Approve Key Financing and Revers - GuruFocus
Accuray appoints Richard A. Meier to Board and Compensation Committee - TradingView
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director - PR Newswire
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director - TradingView
Accuray Incorporated Announces Appointment of Richard A. ("Randy") Meier as Director and Compensation Committee Member, Effective October 6, 2026 - www.marketscreener.com
XEJ Forecast — Price Target — Prediction for 2027 - TradingView
Japan Approves Accuray’s Cyberknife M6 System for Radiation Therapy Patients - mpo-mag.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Accuray shares jump as Samsung NeuroLogica collaboration update sparks rally - Quiver Quantitative
Accuray Incorporated Stock Analysis: Bearish Trends and Key Levels Near Term - The Cryptonomist
Why Is Accuray Stock Gaining Monday? - Benzinga
Why Is Accuray Stock Gaining Monday? - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why is Accuray Incorporated Stock (ARAY) Up 60% Today? - TipRanks
Accuray partners with Samsung NeuroLogica on CyberKnife imaging - Medical Device Network
Accuray partners with Samsung NeuroLogica on CyberKnife imaging - finance.yahoo.com
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform - Investing News Network
Accuray (ARAY) Partners with Samsung HME America to Advance Cybe - GuruFocus
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform - PR Newswire
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform - cherokeephoenix.org
Accuray Incorporated (ARAY) Partners With Samsung NeuroLogica on Volumetric Imaging for CyberKnife - tradingview.com
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform - WAOW
Accuray Incorporated (ARAY) options chain - Yahoo Finance UK
ACCURAY INC SEC Filing (Sep 14, 2026) - Stock Titan
Accuray, RaySearch to Collaborate on Adaptive Radiation Therapy - Bitget
Accuray And Raysearch Agree To Collaboration Integrating Raystation Software - TradingView
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities - TradingView
Accuray and RaySearch agree to collaboration integrating RayStation software with Accuray platforms to accelerate Accuray’s online adaptive capabilities - TradingView
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities - PR Newswire
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities - Investing News Network
Accuray (NASDAQ: ARAY) clears 6.8M shares for investors to resell - Stock Titan
TCW GROUP INC Adds to Accuray Inc (ARAY) Stake -- Shares Trade 7 - GuruFocus
Accuray Stock Price Forecast. Should You Buy ARAY? - StockInvest.us
Accuray Inc (NASDAQ: ARAY) Discloses 18.7% Beneficial Ownership by TCW Including Warrants - Kalkine Media
Accuray | 4: Statement of changes in beneficial ownership of securities-10% Owner TCW GROUP INC - Moomoo
[SCHEDULE 13D/A] ACCURAY INC Amended Major Shareholder Report - Stock Titan
Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter - Yahoo Finance
Accuray Inc FY 2026: Revenue $401.95M, EPS ($0.4) — 10-K Summary - TradingView
Accuray (ARAY) sends definitive proxy to shareholders - Stock Titan
Penny-priced Accuray (NASDAQ: ARAY) warrants set up lender share resales - Stock Titan
Accuray Inc - TradingKey
Accuray Fiscal Q4 Swings to Loss, Revenue Falls - Moomoo
Accuray Inc (ARAY) (Q4 2026) Earnings Call Highlights: Strategic - GuruFocus
ARAY Looks 77.3% Undervalued on GF Value™ Despite Financial Chal - GuruFocus
ARAY|Accuray Inc|Price:0.295|Chg%:-0.020 - TradingKey
Accuray Incorporated Q4 2026 Earnings Call Summary - Yahoo Finance
Accuray earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Accuray Incorporated Q4 Operating Expenses US - Moomoo
Accuray Inc Stock (ARAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Accuray Inc Stock (ARAY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Peralta Leonel | SVP, Chief Operations Officer |
Feb 28 '26 |
Option Exercise |
0.00 |
83,723 |
0 |
83,723 |
| MAYER STEVEN F | Director |
Feb 20 '26 |
Buy |
0.56 |
54,875 |
30,878 |
1,545,620 |
| MAYER STEVEN F | Director |
Feb 19 '26 |
Buy |
0.53 |
69,000 |
36,598 |
1,490,745 |
| MAYER STEVEN F | Director |
Feb 18 '26 |
Buy |
0.53 |
126,125 |
67,199 |
1,421,745 |
| Scott Byron C | Director |
Dec 31 '25 |
Option Exercise |
0.00 |
9,433 |
0 |
162,727 |
| Kill Robert | Former Director |
Dec 22 '25 |
Proposed Sale |
0.92 |
262,809 |
241,784 |
0 |
| Chew Jesse | Officer |
Dec 01 '25 |
Proposed Sale |
1.02 |
19,993 |
20,393 |
0 |
| Winter Suzanne C | Officer |
Dec 01 '25 |
Proposed Sale |
1.02 |
68,058 |
69,419 |
0 |
| Pervaiz Ali | SVP Chief Financial Officer |
Nov 29 '25 |
Option Exercise |
0.00 |
44,025 |
0 |
410,204 |
| Chalke Sandeep | SVP, Chief Commercial Officer |
Nov 29 '25 |
Option Exercise |
0.00 |
50,314 |
0 |
524,283 |
5.67%
7.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):